Pivot Bio Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
386
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Investors
-
31
Pivot Bio General Information
Description
Developer of microbial nitrogen fertilizers designed to replace synthetic nitrogen fertilizers. The company's fertilizer helps farmers grow crops that can capture and metabolize nitrogen from the atmosphere, reducing the need for petrochemical fertilizers, enabling farmers to reduce the cost of farming, improve health and create a future with cleaner water and air.
Contact Information
Website
www.pivotbio.comCorporate Office
- 2910 7th Street
- Suite 120
- Berkeley, CA 94710
- United States
Corporate Office
- 2910 7th Street
- Suite 120
- Berkeley, CA 94710
- United States
Pivot Bio Timeline
Pivot Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 01-Sep-2023 | Cancelled | Generating Revenue | |||
| 7. Later Stage VC (Series D) | 19-Jul-2021 | Completed | Generating Revenue | |||
| 6. Debt - General | 19-Mar-2021 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 30-Apr-2020 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 13-Sep-2018 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 22-Mar-2016 | Completed | Generating Revenue | |||
| 2. Seed Round | 30-Oct-2014 | $750K | $750K | Completed | Startup | |
| 1. Grant | 01-Oct-2011 | $100K | Completed | Startup |
Pivot Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 2,495,552 | $0.001000 | $0.51 | $6.41 | $6.41 | 1x | $6.41 | 11.14% |
| Seed | 384,614 | $0.001000 | $0.21 | $2.6 | $2.6 | 1x | $2.6 | 1.72% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Pivot Bio Comparisons
Industry
Financing
Details
Pivot Bio Competitors (16)
One of Pivot Bio’s 16 competitors is Ostara, a Private Equity-Backed company based in Richmond Heights, MO.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ostara | Private Equity-Backed | Richmond Heights, MO | ||||
| Upcycle | Venture Capital-Backed | Fresno, CA | ||||
| Nutrient TECH | Private Equity-Backed | Dinuba, CA | ||||
| BioWorks ( Agricultural Chemicals) | Private Equity-Backed | Victor, NY | ||||
| EnviroKure | Venture Capital-Backed | Hicksville, OH |
Pivot Bio Patents
Pivot Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023298420-A1 | Seed treatment systems, methods, and agricultural compositions | Pending | 30-Jun-2022 | ||
| AU-2022301301-A9 | Genetically-engineered bacterial strains for improved fixation of nitrogen | Pending | 02-Jul-2021 | ||
| AU-2022301301-A1 | Genetically-engineered bacterial strains for improved fixation of nitrogen | Pending | 02-Jul-2021 | ||
| CA-3218556-A1 | Genetically-engineered bacterial strains for improved fixation of nitrogen | Pending | 02-Jul-2021 | ||
| US-20240294953-A1 | Genetically-engineered bacterial strains for improved fixation of nitrogen | Pending | 02-Jul-2021 | C12P13/00 |
Pivot Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Pivot Bio Investors (31)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AR Audit & Research | Family Office | Minority | ||
| Continental Grain Company | PE/Buyout | Minority | ||
| G2 Venture Partners | Venture Capital | Minority | ||
| Generation Investment Management | Growth/Expansion | Minority | ||
| Hercules Capital | Lender/Debt Provider | Minority |
Pivot Bio Investments (1)
Pivot Bio’s most recent deal was a Grant with Vive Crop Protection for . The deal was made on 02-May-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Vive Crop Protection | 02-May-2017 | Grant | Agricultural Chemicals |
Pivot Bio FAQs
-
When was Pivot Bio founded?
Pivot Bio was founded in 2010.
-
Where is Pivot Bio headquartered?
Pivot Bio is headquartered in Berkeley, CA.
-
What is the size of Pivot Bio?
Pivot Bio has 386 total employees.
-
What industry is Pivot Bio in?
Pivot Bio’s primary industry is Agricultural Chemicals.
-
Is Pivot Bio a private or public company?
Pivot Bio is a Private company.
-
What is Pivot Bio’s current revenue?
The current revenue for Pivot Bio is .
-
How much funding has Pivot Bio raised over time?
Pivot Bio has raised $697M.
-
Who are Pivot Bio’s investors?
AR Audit & Research, Continental Grain Company, G2 Venture Partners, Generation Investment Management, and Hercules Capital are 5 of 31 investors who have invested in Pivot Bio.
-
Who are Pivot Bio’s competitors?
Ostara, Upcycle, Nutrient TECH, BioWorks ( Agricultural Chemicals), and EnviroKure are some of the 16 competitors of Pivot Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
